Envision Financial’s AbbVie ABBV Stock Holding History

Envision Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,043	Closed	-$227K	–	49
2026 Q1	$227K	Buy	+1,043	New	+$231K	0.12%	44

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Envision Financial's ABBV Position: Q2 2026 in Review

Envision Financial sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,043 shares — an estimated $227K sold.

Envision Financial first reported a position in ABBV in Q1 2026 and held it in 1 quarter. The position peaked at $227K in Q1 2026. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Envision Financial reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Envision Financial sold 1,043 AbbVie shares in Q2 2026, an estimated $227K.
Envision Financial first reported a position in AbbVie in Q1 2026 and held it in 1 quarter.
Envision Financial's AbbVie position peaked at $227K in Q1 2026.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Envision Financial's 13F filing for Q2 2026, filed 10 Jul 2026.